TRI Today
Internationally renowned for pioneering, multi-disciplinary research, the Thrombosis Research Institutes are dedicated to the study of thrombosis and related disorders.
Two research establishments in London and Bangalore are united by their shared mission: To provide excellence in thrombosis research, education and patient care and to develop new strategies to prevent and treat thrombosis, thereby reducing healthcare costs and saving millions of lives.
The TRI’s current work involves identifying those at risk and protecting them, reducing further the number of preventable deaths in hospital; developing a vaccine for heart disease; pioneering and coordinating the GARFIELD outcomes research initiative – our worldwide observational programmes which are improving understanding of thrombosis and identifying opportunities for innovation.
- The GARFIELD-AF registry is enhancing the breadth and depth of understanding of stroke prevention in atrial fibrillation and is ultimately helping to develop strategies for improving patient outcomes worldwide
- The GARFIELD-VTE registry is bringing a real-world perspective to the field of venous thrombosis. It is describing the acute and long-term management and outcomes in patient populations representative of everyday clinical practice in more than 20 countries
